Faculty

Institution

Unit

Venue

Jay Lee

University of California, Los Angeles

Affiliations

Department of Medicine

Cardiology

School of Medicine

Department of Medicine

NoneJay Lee is currently serving as a Cardiology faculty at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jay Lee

University of California, Los Angeles

You can click a keyword to filter the displayed items

oncology lung cancer thoracic oncology cancer research medicinal research medicine pharmacology radiation oncology immunology cancer treatment cancer care cancer immunotherapy cancer biology respiratory medicine tumor biology tumor targeting clinical research thoracic surgery anti-cancer agents clinical trials cancer genomics cancer management clinical immunology vaccination experimental medicine surgical oncology cellular therapy medical mycology cancer genetics cancer imaging molecular cancer clinical radiation oncology cancer immunosurveillance chronic inflammation clinical medicine neoadjuvant atezolizumab enzyme inhibition cardiothoracic surgery photomedicine oncogenes cancer prevention vaccine research cancer risk lung cancer patients human saliva resectable nsclc neoadjuvant therapy lung carcinogenesis molecular science cellular biology early detection transcriptomics technology oncologic imaging genitourinary cancers multi-scale studies anti-inflammatory immunomodulation experimental pharmacology experimental pathology clinical therapeutics drug targeting cell regulation t-regulatory cell therapeutic efficacy hematological malignancies myeloid neoplasia proteomic analysis transcriptomic biomarker signature interim analysis multicenter study biomarker data lung cancer chemoprevention myeloid suppressor cells immune modulation angiogenic factor production expert consensus document surgery bronchial neoplasm interventional pulmonology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract Ct215: Efficacy and Safety of Adjuvant (Adj) Atezolizumab (Atezo) From the Phase 2 Lcmc3 Study. Cancer Research (2023)

David Paul CarboneSaiama N. WaqarJamie E. ChaftMark G. KrisBruce E. JohnsonJay M. LeeIgnacio I. WistubaDavid KwiatkowskiPaul BunnKatja SchulzeAnn JohnsonEvelise BrandaoMark AwadKaren L. ReckampAnne C. ChiangAlan NicholasValerie Rusch

tumor targetingmedicinepharmacologycancer careradiation oncologycancer researchmolecular cancerpharmacotherapyanti-cancer agentsclinical trialsdrug discoveryoncologyclinical researchcancer imagingmedicinal researchcancer treatmentcancer biologydrug trials

Neoadjuvant Targeted Therapy in Resectable Nsclc: Current and Future Perspectives. Journal of Thoracic Oncology (2023)

Jay M. LeeCiaran J. McNameeEric TolozaMarcelo V. NegraoJules LinElaine ShumAmy L. CummingsMark G. KrisBoris SepesiIlze BaraNino KurtsikidzeKatja SchulzeCelina NgiamJamie E. Chaft

nanomedicinethoracic surgerytumor targetingmedicineresectable nsclccancer careclinical therapeuticscancer researchsurgical oncologytherapeutic targetsdrug targetingcancer treatmentlung cancerpharmacologythoracic oncologyradiation oncologyclinical radiation oncologyfuture perspectivespharmacotherapyoncology

The American Association for Thoracic Surgery (Aats) 2023 Expert Consensus Document: Staging and Multidisciplinary Management of Patients With Early-Stage Non–Small Cell Lung Cancer. Journal of Thoracic and Cardiovascular Surgery (2023)

Biniam KidaneMatthew BottJonathan SpicerLeah BackhusJamie ChaftNeel ChudgarYolonda ColsonThomas A. D'AmicoElizabeth DavidJay LeeSara NajmehBoris SepesiCatherine ShuJeffrey YangScott SwansonBrendon Stiles

expert consensus documentcancer managementmultidisciplinary managementthoracic surgerycardiothoracic surgerylung cancerhealth sciences

Unresectable Stage III Nsclc Should Not Be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection. Journal of Thoracic Oncology (2023)

Drew MoghanakiAaron LisbergScott OhJay Moon Lee

thoracic oncologyradiation oncologythoracic surgeryoncologycancer treatmentlung cancerneoadjuvant therapy

Lcmc Leader Neoadjuvant Screening Trial: Lcmc4 Evaluation of Actionable Drivers in Early-Stage Lung Cancers.. Journal of Clinical Oncology (2022)

Boris SepesiDavid Randolph JonesBryan F. MeyersJamie E. ChaftLynette M. ShollYu ShyrKaren KellyJules LinPaul A. BunnJohn D. MinnaValerie W. RuschIgnacio Ivan WistubaDavid J. KwiatkowskiDavid Paul CarboneLynne D. BerryJay M. LeeKhaled TolbaMark G. Kris

actionable driversearly-stage lung cancerslcmc leadercancer screeningcancer riskcancer carecancer managementhealth sciencesclinical mycologycancer researchcancer treatmentlung cancermedical mycologypharmacologythoracic oncologyradiation oncologyclinical trialsclinical researchoncologyrespiratory medicinemedicinal research

Surgical Results of the Lung Cancer Mutation Consortium 3 Trial: A Phase II Multicenter Single-Arm Study to Investigate the Efficacy and Safety of Atezolizumab as Neoadjuvant Therapy in Patients With Stages Ib-Select Iiib Resectable Non–Small Cell Lung Cancer. Journal of Thoracic and Cardiovascular Surgery (2022)

Valerie W. RuschAlan NicholasG. Alexander PattersonSalama N. WaqarEric M. TolozaEric B. HauraDan J. RazKaren L. ReckampRobert E. MerrittDwight H. OwenDavid J. FinleyCiaran J. McNameeJustin D. BlasbergEdward B. GaronJohn D. MitchellRobert C. DoebeleFrank BaciewiczMisako NagasakaHarvey I. PassKatja SchulzeAnn JohnsonPaul A. BunnBruce E. JohnsonMark G. KrisDavid J. KwiatkowskiIgnacio I. WistubaJamie E. ChaftDavid P. CarboneJay M. Lee

surgeryradiologycancer carecancer geneticsthoracic oncologyradiation oncologycancer researchsurgical oncologythoracic surgeryclinical trialsoncologycancer treatmenttherapeutic efficacylung cancerneoadjuvant therapy

Artificial Intelligence (AI)–Powered Pathologic Response (Pathr) Assessment of Resection Specimens After Neoadjuvant Atezolizumab in Patients With Non-Small Cell Lung Cancer: Results From the Lcmc3 Study.. Journal of Clinical Oncology (2021)

Sanja DacicWilliam D. TravisJennifer Margaret GiltnaneJohn AbelFilip KosStephanie HilzStephanie HennekJunya FujimotoLynette M. ShollFarah KhalilJon RitterMassimo D'ApuzzoJay M. LeeValerie W. RuschDavid Paul CarboneAlan NicholasAnn JohnsonKatja SchulzeMark G. KrisIgnacio Ivan Wistuba

neoadjuvant atezolizumabpathologyresection specimenspathologic responsemedicineoutcomes researchcancer carecancer managementartificial intelligencecancer researchcancer treatmentlung cancerdisease assessmentthoracic oncologyradiation oncologyclinical radiation oncologybenchmark studiesoncologyrespiratory medicine

Ccl21-DC Tumor Antigen Vaccine Augments Anti-Pd-1 Therapy in Lung Cancer. AIMS Medical Science (2021)

Sherven SharmaPournima KadamRam P SinghMichael DavoodiMaie St JohnJay M Lee

immunologyvaccinesmedicinetumor targetingcancer carethoracic oncologyvaccine developmentclinical medicinecancer immunotherapyoncologyrespiratory medicinevaccinationmedicinal researchcancer treatmentlung cancerhealth sciencesmedical technology

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable Nsclc. JTO Clinical and Research Reports (2021)

Jay M. LeeAnthony W. KimTomasz MarjanskiPierre-Emmanuel FalcozMasahiro TsuboiYi-Long WuShawn W. SunBarbara J. Gitlitz

surgeryresectable nsclcneoadjuvant immunotherapy trialsclinical trialsclinical researchclinical end pointsimmunotherapy

Technical Feasibility and Safety of Repeated Computed Tomography–Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic Nsclc. JTO Clinical and Research Reports (2021)

Puja ShahroukiJay M. LeeJonathan BarclaySarah N. KhanScott GenshaftFereidoun AbtinSteven M. DubinettAaron LisbergSherven SharmaEdward B. GaronRobert Suh

nanomedicinetherapeutic imagingnovel therapiesclinical case reportgene-modified cellular immunotherapymedicinetechnical feasibilitydermatologycancer researchcancer treatmentbiomedical imaginglung cancerradiologymetastatic nsclccomputed tomographycancer imagingclinical researchoncologymedicinal researchclinical investigationexperimental medicine

1
2
3
4
5
10 / page

Jay Lee

University of California, Los Angeles

Affiliations

Department of Medicine

Cardiology

School of Medicine

Department of Medicine

NoneJay Lee is currently serving as a Cardiology faculty at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jay Lee

University of California, Los Angeles

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract Ct215: Efficacy and Safety of Adjuvant (Adj) Atezolizumab (Atezo) From the Phase 2 Lcmc3 Study. Cancer Research (2023)

Neoadjuvant Targeted Therapy in Resectable Nsclc: Current and Future Perspectives. Journal of Thoracic Oncology (2023)

Jay M. LeeCiaran J. McNameeEric TolozaMarcelo V. NegraoJules LinElaine ShumAmy L. CummingsMark G. KrisBoris SepesiIlze BaraNino KurtsikidzeKatja SchulzeCelina NgiamJamie E. Chaft

expert consensus documentcancer managementmultidisciplinary managementthoracic surgerycardiothoracic surgerylung cancerhealth sciences

Unresectable Stage III Nsclc Should Not Be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection. Journal of Thoracic Oncology (2023)

Drew MoghanakiAaron LisbergScott OhJay Moon Lee

thoracic oncologyradiation oncologythoracic surgeryoncologycancer treatmentlung cancerneoadjuvant therapy

Lcmc Leader Neoadjuvant Screening Trial: Lcmc4 Evaluation of Actionable Drivers in Early-Stage Lung Cancers.. Journal of Clinical Oncology (2022)

Ccl21-DC Tumor Antigen Vaccine Augments Anti-Pd-1 Therapy in Lung Cancer. AIMS Medical Science (2021)

Sherven SharmaPournima KadamRam P SinghMichael DavoodiMaie St JohnJay M Lee

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable Nsclc. JTO Clinical and Research Reports (2021)

Jay M. LeeAnthony W. KimTomasz MarjanskiPierre-Emmanuel FalcozMasahiro TsuboiYi-Long WuShawn W. SunBarbara J. Gitlitz

surgeryresectable nsclcneoadjuvant immunotherapy trialsclinical trialsclinical researchclinical end pointsimmunotherapy

Puja ShahroukiJay M. LeeJonathan BarclaySarah N. KhanScott GenshaftFereidoun AbtinSteven M. DubinettAaron LisbergSherven SharmaEdward B. GaronRobert Suh

1
2
3
4
5
10 / page

Similar Faculty Members

Daniel H. Sterman

Institution

New York University

multiple pulmonary nodule

lung cancer

Anil Vachani

Institution

University of Pennsylvania

radiology

respiratory medicine

Dwight H Owen

Institution

Ohio State University

evolutionary data mining

optimization-based data mining

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Zhang Jianjun

Institution

University of California, Los Angeles

oncology

cancer research

Jeffrey Crawford

Institution

Duke University

mesothelioma

cancer care

Scott Joseph Antonia

Institution

Duke University

oncology

cancer research

Gerard Lozanski

Institution

Ohio State University

pathology

hematological malignancies

Sanjib Basu

Institution

University of Illinois Chicago

oncology

cancer research

Similar Faculty Members

Daniel H. Sterman

Institution

New York University

multiple pulmonary nodule

lung cancer

Anil Vachani

Institution

University of Pennsylvania

radiology

respiratory medicine

Dwight H Owen

Institution

Ohio State University

evolutionary data mining

optimization-based data mining

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Zhang Jianjun

Institution

University of California, Los Angeles

oncology

cancer research

Jeffrey Crawford

Institution

Duke University

mesothelioma

cancer care

Scott Joseph Antonia

Institution

Duke University

oncology

cancer research

Gerard Lozanski

Institution

Ohio State University

pathology

hematological malignancies

Sanjib Basu

Institution

University of Illinois Chicago

oncology

cancer research